Cardinal Health to sell Chinese distribution business to Shanghai Pharma

Cardinal Health on Tuesday signed a definitive agreement to divest its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. for $1.2 billion.

Advertisement

Here are three things to know.

1. The deal involves Cardinal Health’s drug and medical products distribution business in China, but does not apply to the company’s remaining businesses in the country.

2. Eric Zwisler, chairman of Cardinal Health China, will also retire, effective immediately, as part of the transaction.

3. Cardinal Health expects the transaction to close by the end of its fiscal year.

More articles on supply chain:

Prime Healthcare taps HealthTrust for GPO services
Acorda Therapeutics halts Parkinson’s drug trials after 5 patient deaths
Hospitals face critical saline bag shortage: 6 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.